Checkpoint Therapeutics, Inc. ("Checkpoint”) (Nasdaq: CKPT), a commercial-stage immunotherapy and targeted oncology company, ...
Understanding the scale of the problem is the first step to addressing it. Scientists issue stark warning about growing ...
Phase 1 dose-escalation study continues with data readout expected mid-2025; Dose expansion data readout anticipated ...
A recent study published in Engineering has shed new light on the mechanisms underlying the metastasis of head and neck squamous cell carcinoma (HNSCC). The research identified enolase 2 (ENO2), a ...
A team of Singapore scientists has made a significant discovery in understanding stomach cancer, a disease that remains one ...
Candel Therapeutics has identified a subpopulation of lung cancer patients living longest on its oncolytic virus, leading the biotech to narrow its focus as it heads towards a potentially ...
A new study published in Engineering has identified enolase 2 (ENO2) as a key factor in the lymphatic metastasis of head and ...
Researchers at City of Hope have found that cell mutations are necessary but not always sufficient for tumors to form.
Katie Thurston’s husband Jeff Arcuri explained why he wanted to push their wedding plans up and marry the Bachelor Nation ...
Cells don’t just follow a rigid script when responding to stress – they’re far more adaptable than we thought. A new study ...
Neoadjuvant chemoimmunotherapy is associated with significantly improved survival outcomes compared with standard ...
Expression data from patient-derived xenograft (PDX) mouse models exposed to micvotabart pelidotin (MICVO) indicate gene signatures associated ...